International safety notice

Alert 2640 (Technosurveillance) - Werfen Medical Ltda.

Brazil / Anvisa · BRA · Aug 9, 2018

Key facts

Title Alert 2640 (Technosurveillance) - Werfen Medical Ltda.
Regulator Brazil / Anvisa
Country BRA
Brand Nome Comercial: HemosIL ReadiPlasTin Technical Name: Prothrombin Time (PT) ANVISA registration number: 80003610530 Risk Class: III Modelo afetado: ReadiPlasTin Reagent: 5 x 0.5 mL, ReadiPlasTin Diluent: 5 x 9.5 mL Affected serial numbers: N0278177 (20 units)
Manufacturer EMPRESA DETENTORA DO REGISTRO WERFEN MEDICAL LTDA CNPJ 02004662000165 ESTRADA DOS ROMEIROS KM 385 CONDOMÍNIO MORRO GRANDE MÓD G9 N 138 SANTANA DE PARNAÍBA SP TEL 11 46227878 EMAIL EURIDIANAGARCIAWERFENCOM FABRICANTE DO PRODUTO INSTRUMENTATION LABORATORY 180 HARTWELL ROAD BEDFORD MA 017302443 ESTADOS UNIDOS DA AMÉRICA
Models N0278177, 80003610530
Date Aug 9, 2018
Regulator page anvisa.gov.br

At a glance

  • No Recall
  • No Field safety notice

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About International device safety notices

Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.

Source: National medical device regulators (as listed), compiled by Orca1

Browse all International device safety notices